Top Story

Omeros reports $18.7 million net loss in first quarter

May 27, 2015

Omeros reported a net loss of $18.7 million, or $0.51 per share, in the first quarter 2015 vs. a net loss of $16.6 million, or $0.54 per share, in the first quarter 2014, according to a press release.

The company had a controlled launch of Omidria (1% phenylephrine and 0.3% ketorolac injection) in the first quarter, which resulted in product revenue of $238,000. Grant revenue was $150,000 compared with $100,000 in the first quarter 2014.

Publication Exclusive: Gore-Tex suture can be used in small-incision scleral fixation of hydrophilic acrylic IOL

May 27, 2015
Secondary IOL placement is often associated with an IOL exchange due to previous IOL subluxation or dislocation and, less commonly, aphakic correction. The location of…
Business News

Eylea US net sales increase 51% in first quarter

May 26, 2015
Eylea net sales in the U.S. increased 51% to $541 million in the first quarter of 2015 from $359 million in the first quarter of 2014, according to a press release from…

BLOG: Take a closer look at alternate eye care delivery

May 26, 2015
Eye care has traditionally been delivered in a doctor’s office. Although the setting has changed over the last century from only the classic “private…
Noel Alpins In the JournalsPerspective

Cassini topographer shows parity with other devices

May 26, 2015
A novel keratometer with colored light-emitting diodes generated cylinder measurements comparable to those obtained with Placido rings, monochromatic LEDs and…
More News Headlines »
Video
Agustin Gonzalez

BLOG: Keep your enemies close

April 28, 2015
Agustin L. Gonzalez, OD, FAAO, reminds us of the adage: “Keep your friends close, but your enemies…
More »
morganatic-roan